Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
Acta Neurochirurgica|September 19, 2021
Endovascular treatment of an infectious aneurysm using the selective provocative test and transcranial motor evoked potential monitoring under general anesthesia: a case reportKazuhiro Ando, Tetsuya Hiraishi, Makoto Oishi, et al.
Neurologia Medico-Chirurgica|February 22, 2019
EGFRvIII Is Expressed in Cellular Areas of Tumor in a Subset of GlioblastomaTakanori Nozawa, Masayasu Okada, Manabu Natsumeda, et al.
NMC Case Report Journal|October 14, 2022
Meningoencephalocele in the Lateral Sphenoid Sinus Showing Malformation of Cortical Development: A Case ReportTaro Sato, Tetsuya Hiraishi, Mari Tada, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|May 8, 2015
Immunohistochemical profiles of IDH1, MGMT and P53: practical significance for prognostication of patients with diffuse gliomasRyosuke Ogura, Yoshihiro Tsukamoto, Manabu Natsumeda, et al.
Journal of the Neurological Sciences|July 27, 2024
Indications for a brain biopsy in neurological diseases of unknown etiology: The role of magnetic resonance imaging findings and liquid biopsy in yielding definitive pathological diagnosesToshiya Kizaki, Masato Kanazawa, Takanobu Ishiguro, et al.
Journal of Neurosurgery|January 4, 2023
Intranasal delivery of nanoliposomal SN-38 for treatment of diffuse midline gliomaTakahiro Sasaki, Jun Watanabe, Xingyao He, et al.
Acta Neuropathologica Communications|November 8, 2014
Accumulation of 2-hydroxyglutarate in gliomas correlates with survival: a study by 3.0-tesla magnetic resonance spectroscopyManabu Natsumeda, Hironaka Igarashi, Toshiharu Nomura, et al.
Cancers|February 15, 2022
Novel Repositioning Therapy for Drug-Resistant Glioblastoma: In Vivo Validation Study of Clindamycin Treatment Targeting the mTOR Pathway and Combination Therapy with TemozolomideTakeyoshi Eda, Masayasu Okada, Ryosuke Ogura, et al.
Diagnostics (Basel, Switzerland)|November 27, 2021
Detection of 2-Hydroxyglutarate by 3.0-Tesla Magnetic Resonance Spectroscopy in Gliomas with Rare IDH Mutations: Making Sense of "False-Positive" CasesManabu Natsumeda, Hironaka Igarashi, Ramil Gabdulkhaev, et al.
Diagnostics (Basel, Switzerland)|April 30, 2021
Low Detection Rate of H3K27M Mutations in Cerebrospinal Fluid Obtained from Lumbar Puncture in Newly Diagnosed Diffuse Midline GliomasJotaro On, Manabu Natsumeda, Jun Watanabe, et al.
Pageof 11